Association between functional inhibitors of acid sphingomyelinase (fiasmas) and reduced risk of death in covid-19 patients: a retrospective cohort study

HIGHLIGHTS

• who: Gil Darquennes and collaborators from the Department of Psychiatry, Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, BelgiumIrset (Institut de Recherche en Santé, Environnement et Travail)-UMR_S, University of Rennes, CHU Rennes, INSERM, EHESP, Rennes, France have published the Article: Association between Functional Inhibitors of Acid Sphingomyelinase (FIASMAs) and Reduced Risk of Death in COVID-19 Patients: A Retrospective Cohort Study, in the Journal: Pharmaceuticals 2021, 14, x FOR PEER REVIEW of 31/08/2020
• what: It must be noted that in almost all the studies, the FIASMA status was not identified for . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.